Sotac Pharmaceuticals Financials
NSE: SOTAC
₹90.05
₹0.00 (0.00%)As on 04-Sep-2026 10:54IST
Market cap
₹100 Cr
Revenue (TTM)
₹97 Cr
P/E Ratio
17.3
P/B Ratio
1.8
Div. Yield
0.2 %
Income Statement (₹ Cr) |
Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
96.99
|
103.83
|
77.48
|
73.15
|
48.84
|
28.60
|
|
|
|
|
|
|
Total Income
|
100.88
|
104.32
|
77.83
|
73.37
|
48.95
|
28.83
|
|
|
|
|
|
|
Total Expenditure
|
83.35
|
95.51
|
70.17
|
66.98
|
47.39
|
26.74
|
|
|
|
|
|
|
EBITDA
|
13.64
|
8.32
|
7.32
|
6.17
|
1.46
|
1.87
|
|
|
|
|
|
|
Depreciation
|
3.84
|
3.10
|
2.28
|
1.13
|
2.59
|
1.40
|
|
|
|
|
|
|
EBIT
|
9.80
|
5.22
|
5.04
|
5.05
|
-1.14
|
0.47
|
|
|
|
|
|
|
Interest
|
2.58
|
1.74
|
2.04
|
0.57
|
1.03
|
0.33
|
|
|
|
|
|
|
Other Income
|
3.90
|
0.49
|
0.35
|
0.22
|
0.11
|
0.22
|
|
|
|
|
|
|
Exceptional Items
|
--
|
--
|
0.58
|
--
|
--
|
--
|
|
|
|
|
|
|
Profit before Tax
|
11.12
|
3.96
|
3.93
|
4.69
|
-2.06
|
0.36
|
|
|
|
|
|
|
Provision for Tax
|
1.84
|
0.38
|
1.64
|
1.82
|
0.31
|
0.27
|
|
|
|
|
|
|
Profit after Tax
|
9.28
|
3.58
|
2.29
|
2.88
|
-2.37
|
0.09
|
|
|
|
|
|
|
Minority Interest
|
-1.25
|
0.70
|
0.59
|
--
|
--
|
--
|
|
|
|
|
|
|
Share of Associate
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Consolidated Profit
|
8.03
|
4.28
|
2.88
|
2.88
|
-2.37
|
0.09
|
|
|
|
|
|
Liabilities (₹ Cr) |
Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
53.25
|
45.26
|
19.46
|
6.62
|
2.49
|
3.06
|
|
|
|
|
|
|
Minority Interest
|
5.17
|
4.07
|
0.23
|
--
|
0.07
|
1.66
|
|
|
|
|
|
|
Non-Current Liabilities
|
13.06
|
10.84
|
8.14
|
1.01
|
9.37
|
6.33
|
|
|
|
|
|
|
Current Liabilities
|
51.55
|
43.73
|
45.81
|
27.61
|
22.76
|
19.34
|
|
|
|
|
|
|
Total Liabilities
|
124.33
|
105.33
|
73.64
|
35.25
|
34.70
|
30.38
|
|
|
|
|
|
Assets (₹ Cr) |
Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
53.20
|
43.25
|
26.50
|
9.36
|
17.35
|
16.63
|
|
|
|
|
|
|
Current Assets
|
69.83
|
60.65
|
47.14
|
25.88
|
17.35
|
13.75
|
|
|
|
|
|
|
Total Assets
|
124.33
|
105.33
|
73.64
|
35.25
|
34.70
|
30.38
|
|
|
|
|
|
|
Total Debt*
|
43.70
|
24.86
|
22.04
|
7.39
|
17.13
|
13.44
|
|
|
|
|
|
|
Net Current Assets
|
18.28
|
16.92
|
1.33
|
-1.73
|
-5.41
|
-5.59
|
|
|
|
|
|
|
Contingent Liabilities
|
1.53
|
0.46
|
--
|
0.40
|
--
|
--
|
|
|
|
|
|
Cashflow (₹ Cr) |
Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-4.33
|
-16.08
|
8.14
|
6.35
|
-0.31
|
0.06
|
|
|
|
|
|
|
Cash Flow from Investing Activities
|
-13.62
|
-19.68
|
-11.67
|
-3.52
|
-3.23
|
-11.75
|
|
|
|
|
|
|
Cash from Financing Activities
|
16.09
|
29.49
|
13.14
|
-2.83
|
3.38
|
11.40
|
|
|
|
|
|
|
Net Cash Inflow / Outflow
|
-1.85
|
-6.26
|
9.61
|
0.00
|
-0.16
|
-0.29
|
|
|
|
|
|
Financials Ratios |
Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
7.26
|
3.87
|
3.58
|
3.58
|
-2.94
|
0.11
|
|
|
|
|
|
|
Cash EPS (₹)
|
11.86
|
6.05
|
5.67
|
4.98
|
0.28
|
1.85
|
|
|
|
|
|
|
Adjusted Book Value (₹)
|
48.19
|
40.96
|
12.41
|
8.23
|
3.10
|
3.80
|
|
|
|
|
|
|
Dividend per Share (₹)
|
0.10
|
--
|
--
|
2.00
|
--
|
--
|
|
|
|
|
|
|
Cash Flow per Share (₹)
|
-3.92
|
-14.55
|
10.12
|
27.61
|
-1.33
|
0.25
|
|
|
|
|
|
|
Free Cash Flow per Share (₹)
|
-22.46
|
-24.19
|
-3.56
|
2.55
|
-19.74
|
-44.98
|
|
|
|
|
|
Profitability Ratios |
Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
16.40
|
10.22
|
21.50
|
31.31
|
-5.71
|
4.18
|
|
|
|
|
|
|
ROE (%)
|
18.83
|
12.96
|
27.53
|
63.16
|
-85.23
|
2.86
|
|
|
|
|
|
|
ROA (%)
|
8.17
|
4.03
|
4.20
|
8.23
|
-7.27
|
0.29
|
|
|
|
|
|
|
EBIT Margin (%)
|
10.11
|
5.02
|
6.50
|
6.90
|
-2.33
|
1.63
|
|
|
|
|
|
|
Net Margin (%)
|
9.19
|
3.43
|
2.94
|
3.92
|
-4.83
|
0.30
|
|
|
|
|
|
|
Cash Profit Margin (%)
|
13.52
|
6.43
|
5.89
|
5.48
|
0.47
|
5.20
|
|
|
|
|
|
Growth Ratios |
Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-6.59
|
34.00
|
5.92
|
49.77
|
70.76
|
--
|
|
|
|
|
|
|
EBIT Growth (%)
|
87.96
|
3.52
|
-0.15
|
543.63
|
-343.50
|
--
|
|
|
|
|
|
|
Net Profit Growth (%)
|
159.14
|
56.57
|
-20.58
|
221.70
|
-2,803.31
|
--
|
|
|
|
|
|
|
EPS Growth (%)
|
87.48
|
8.32
|
0.03
|
221.70
|
-2,803.31
|
--
|
|
|
|
|
|
|
Book Value Growth (%)
|
17.66
|
353.10
|
50.84
|
165.56
|
-18.44
|
--
|
|
|
|
|
|
Valuation Ratios |
Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
16.35
|
31.23
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Price / Book Value
|
2.46
|
2.95
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Dividend Yield (%)
|
0.08
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
EV/EBITDA
|
9.89
|
17.63
|
2.66
|
1.51
|
12.26
|
7.33
|
|
|
|
|
|
|
Close Price (₹)
|
118.75
|
121.00
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
High Price (₹)
|
202.80
|
155.00
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Low Price (₹)
|
87.10
|
97.00
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Market Cap (₹ Cr)
|
131.22
|
133.70
|
--
|
--
|
--
|
--
|
|
|
|
|
|
Solvency Ratios |
Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
0.82
|
0.55
|
2.21
|
1.12
|
6.87
|
4.40
|
|
|
|
|
|
|
Short term debt to equity ratio
|
0.35
|
0.22
|
0.56
|
0.78
|
2.63
|
2.17
|
|
|
|
|
|
|
Current Ratio
|
1.35
|
1.39
|
1.03
|
0.94
|
0.76
|
0.71
|
|
|
|
|
|
|
Quick Ratio
|
0.96
|
0.98
|
0.73
|
0.74
|
0.55
|
0.59
|
|
|
|
|
|
|
Interest Coverage
|
5.31
|
3.28
|
2.92
|
9.24
|
-1.01
|
2.07
|
|
|
|
|
|
Operating Efficiency Ratios |
Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
35.17
|
25.32
|
19.02
|
16.75
|
12.05
|
24.33
|
|
|
|
|
|
|
Asset Turnover
|
0.85
|
1.17
|
1.42
|
2.09
|
1.50
|
0.94
|
|
|
|
|
|
|
Receivable days
|
113.65
|
72.11
|
63.58
|
45.25
|
47.99
|
88.82
|
|
|
|
|
|
|
Inventory Days
|
72.01
|
55.63
|
44.84
|
25.51
|
26.72
|
29.65
|
|
|
|
|
|
|
Payable days
|
127.81
|
124.45
|
143.83
|
106.65
|
112.91
|
193.78
|
|
|
|
|
|
|
Cash Conversion Cycle
|
57.86
|
3.30
|
-35.41
|
-35.90
|
-38.19
|
-75.32
|
|
|
|
|
|
loading...
loading...
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
